-
Soluble CD4 molecules neutralize human immunodeficiency virus type 1.
Nature. 1988 Jan 7;331(6151):84-6
PMID: 2829024
-
Quantitative measurement of fusion between human immunodeficiency virus and cultured cells using membrane fluorescence dequenching.
FEBS Lett. 1988 Oct 24;239(1):88-92
PMID: 2846352
-
HIV infection is blocked in vitro by recombinant soluble CD4.
Nature. 1988 Jan 7;331(6151):76-8
PMID: 2829022
-
Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
Nature. 1986 Jul 31-Aug 6;322(6078):470-4
PMID: 3016552
-
Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion.
Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8082-6
PMID: 1896455
-
Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2189-93
PMID: 2006155
-
Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.
Nature. 1986 Oct 23-29;323(6090):725-8
PMID: 3095663
-
Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.
Science. 1986 Jan 24;231(4736):382-5
PMID: 3001934
-
Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4.
J Virol. 1991 Mar;65(3):1133-40
PMID: 1995942
-
pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane.
Cell. 1987 Jun 5;49(5):659-68
PMID: 3107838
-
Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4.
J Virol. 1989 Oct;63(10):4370-5
PMID: 2550671
-
Designing CD4 immunoadhesins for AIDS therapy.
Nature. 1989 Feb 9;337(6207):525-31
PMID: 2536900
-
Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by recombinant soluble CD4 and 3'-azido-3'-deoxythymidine.
J Infect Dis. 1989 May;159(5):837-44
PMID: 2785146
-
Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism.
EMBO J. 1988 Feb;7(2):513-8
PMID: 3259178
-
A soluble form of CD4 (T4) protein inhibits AIDS virus infection.
Nature. 1988 Jan 7;331(6151):82-4
PMID: 3257544
-
Glycosylation of CD4. Tunicamycin inhibits surface expression.
J Biol Chem. 1988 Jul 5;263(19):9502-7
PMID: 3259951
-
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV.
Nature. 1984 Dec 20-1985 Jan 2;312(5996):767-8
PMID: 6083454
-
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.
Nature. 1984 Dec 20-1985 Jan 2;312(5996):763-7
PMID: 6096719
-
Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen.
Science. 1987 Dec 18;238(4834):1704-7
PMID: 3500514
-
Cytofluorometric quantification of cell-surface antigens by indirect immunofluorescence using monoclonal antibodies.
J Immunol Methods. 1985 Dec 17;85(1):65-74
PMID: 3908562
-
A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site.
Cell. 1990 Mar 9;60(5):747-54
PMID: 2107024
-
Chemically induced CD4 mutants of a human T cell line. Evidence for dissociation between binding of HIV I envelope and susceptibility to HIV I infection and syncytia formation.
J Immunol. 1990 Mar 15;144(6):2131-9
PMID: 1690235
-
HIV: early virus-cell interactions.
J Acquir Immune Defic Syndr. 1990;3(10):965-74
PMID: 2398460
-
HIV requires multiple gp120 molecules for CD4-mediated infection.
Nature. 1990 Jul 19;346(6281):277-9
PMID: 2374593
-
The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.
Ann Intern Med. 1990 Feb 15;112(4):254-61
PMID: 2297204
-
Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial.
Ann Intern Med. 1990 Feb 15;112(4):247-53
PMID: 2297203
-
Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses.
J Virol. 1991 Jan;65(1):31-41
PMID: 1985202
-
Dissociation of gp120 from HIV-1 virions induced by soluble CD4.
Science. 1990 Nov 23;250(4984):1139-42
PMID: 2251501
-
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.
Cell. 1986 Nov 7;47(3):333-48
PMID: 3094962
-
A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.
Nature. 1988 Jan 7;331(6151):78-81
PMID: 2829023